Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Hyperfine, Inc. (HYPR)

0.8295 -0.0037 (-0.44%)
As of 11:22:59 AM EDT. Market Open.
Chart Range Bar
Loading chart for HYPR
  • Previous Close 0.8332
  • Open 0.8311
  • Bid 0.7416 x 200
  • Ask 1.2300 x 200
  • Day's Range 0.8125 - 0.8416
  • 52 Week Range 0.8125 - 2.2200
  • Volume 153,700
  • Avg. Volume 981,288
  • Market Cap (intraday) 87.967M
  • Beta (5Y Monthly) 1.43
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3700
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.03

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.

www.hyperfinemri.com

102

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 8/31/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HYPR
15.27%
S&P 500 (^GSPC)
12.16%

1-Year Return

HYPR
33.10%
S&P 500 (^GSPC)
18.84%

3-Year Return

HYPR
59.73%
S&P 500 (^GSPC)
70.32%

5-Year Return

HYPR
91.63%
S&P 500 (^GSPC)
69.76%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 3.9M
Earnings -9.3M
Profit Margin -238.17%

Q2

FY25

Q3

FY25

Q4

FY25

Q2

FY26

-10M
-5M
0
5M
-300.0%
-250.0%
-200.0%
-150.0%

Analyst Insights

View More

Analyst Price Targets

1.60
2.03 Average
0.8295 Current
2.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/10/2026
Analyst B. Riley Securities
Rating Action Reiterates
Rating Buy
Price Action Lowers
Price Target 2 -> 1.6

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    89.78M

  • Enterprise Value

    59.74M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.75

  • Price/Book (mrq)

    2.44

  • Enterprise Value/Revenue

    3.61

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -210.75%

  • Return on Assets (ttm)

    -38.82%

  • Return on Equity (ttm)

    -96.97%

  • Revenue (ttm)

    16.54M

  • Net Income Avi to Common (ttm)

    -34.85M

  • Diluted EPS (ttm)

    -0.3700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    43.46M

  • Total Debt/Equity (mrq)

    36.49%

  • Levered Free Cash Flow (ttm)

    -17.16M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.8295 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: